Correlation Between Okta and Organogenesis Holdings
Can any of the company-specific risk be diversified away by investing in both Okta and Organogenesis Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Okta and Organogenesis Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Okta Inc and Organogenesis Holdings, you can compare the effects of market volatilities on Okta and Organogenesis Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Okta with a short position of Organogenesis Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Okta and Organogenesis Holdings.
Diversification Opportunities for Okta and Organogenesis Holdings
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Okta and Organogenesis is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Okta Inc and Organogenesis Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organogenesis Holdings and Okta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Okta Inc are associated (or correlated) with Organogenesis Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organogenesis Holdings has no effect on the direction of Okta i.e., Okta and Organogenesis Holdings go up and down completely randomly.
Pair Corralation between Okta and Organogenesis Holdings
Given the investment horizon of 90 days Okta is expected to generate 2.51 times less return on investment than Organogenesis Holdings. But when comparing it to its historical volatility, Okta Inc is 1.8 times less risky than Organogenesis Holdings. It trades about 0.03 of its potential returns per unit of risk. Organogenesis Holdings is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 265.00 in Organogenesis Holdings on August 28, 2024 and sell it today you would earn a total of 139.00 from holding Organogenesis Holdings or generate 52.45% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Okta Inc vs. Organogenesis Holdings
Performance |
| Timeline |
| Okta Inc |
| Organogenesis Holdings |
Okta and Organogenesis Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Okta and Organogenesis Holdings
The main advantage of trading using opposite Okta and Organogenesis Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Okta position performs unexpectedly, Organogenesis Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organogenesis Holdings will offset losses from the drop in Organogenesis Holdings' long position.The idea behind Okta Inc and Organogenesis Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Organogenesis Holdings vs. Shuttle Pharmaceuticals | Organogenesis Holdings vs. Lifecore Biomedical | Organogenesis Holdings vs. Redhill Biopharma | Organogenesis Holdings vs. Collegium Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |